REGULATORY

• Label Revisions Ordered for Xtandi, Paxlovid, and More Drugs
  April 9, 2025

• Revise Regulations of Clinical Trial Info in PMD Act: Patient Advocate to Diet
  April 9, 2025

• FPMAJ Renews Call for Scrapping Off-Year Drug Price Revision: Diet Hearing
  April 9, 2025

• Japan Economic Minister Akazawa to Lead Tariff Talks with US
  April 9, 2025

• PMDA Announces Guidance on “Competing Products” in Regulatory Review
  April 8, 2025

• MHLW Now Soliciting Bids for FY2025 Budget Projects to Fight Drug Lag/Loss
  April 8, 2025

• Ishiba, Trump Agree to Appoint Ministers for Tariffs Talks
  April 8, 2025

• Public-Private Council Will Meet This Summer: Japan PM
  April 8, 2025

• Ishin Prods Govt to End Fee Incentives for Generic Use, Minister Says Topic Up for Chuikyo Discussions
  April 7, 2025

• Diet Begins Deliberations on Amendment of PMD Act, Bill to Repeal Off-Year Scheme
  April 7, 2025

• Shingles Shots Added to NIP, HPV Catch-Up Program Extended: MHLW
  April 7, 2025

• LDP’s New Fiscal Reform HQ to Release Draft Report by Late May
  April 4, 2025

• 3-Party Talks Fail to Reach Specifics on OTC-Like Drugs
  April 4, 2025

• Japan Mulls Amendment of GCP Ordinance, Making Single IRBs a Rule
  April 3, 2025

• JIHS Now Up and Running as Japan Version of CDC
  April 3, 2025

• PMD Act Amendment to Enter Diet Debate; Parallel Deliberations Planned for Bill to Scrap Off-Year Revisions
  April 3, 2025

• Japan Picks 14 “Loss” Products as Drugs with Highest Priority for Development
  April 2, 2025

• GSK’s Shingrix Buttresses Label with Long-Term Data
  April 2, 2025

• MHLW Says It Will Handle Info Disclosure Requests as per Rules
  April 2, 2025

• MHLW Doles Out Orphan Tags to 12 Compounds
  April 1, 2025

ページ

• « 先頭
• ‹ Prev
• …
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• …
• Next ›
• 最終 »